Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
GenMark Diagnostics prices $42 million secondary offering. Oxford Immunotec raises $28 million for TB test commercialization efforts. Benvenue Medical gets $25 million for spinal devices. More financings.
You may also be interested in...
People In Brief
Personnel announcements from Atricure, EndoGastric Solutions, Mehri & Skalet.
New Products In Brief
Recent approvals and launches include St. Jude Medical’s EnligHTN renal denervation system for hypertension and Zeltiq Aesthetics’ expanded CoolSculpting clearance for fat reduction.
New Products In Brief
The latest product approvals and launches.